MA
Mpm Asset Management LLC
High-turnover traderConcentrated strategyQuality / disciplined sizing
Total reported value
$44.5M
Reporting period: 2025-09-30 · Number of holdings: 4
MPM ASSET MANAGEMENT LLC disclosed 4 holdings in its latest 13F filing for the period ending 2025-09-30, with total reported value of $44.5M and a quarterly turnover rate of 100.0%.
Personality snowflake
- Concentration
- 100
- Portfolio Stability
- 100
- Momentum/Contrarian
- 50
- Sector conviction
- 0
- Diversification
- 8
- Sizing Uniformity
- 91
Recent moves
Add HOWL
0.0% -$4.2B
Add DYN
0.0% -$7.1B
Add RPTX
0.0% -$1.1B
Add TRDA
0.0% -$39.6B
Sold out 2662247D
Sold out ADAPY
Holdings Map
New buyAddUnchangedTrim
Top 10 holdings by weight
Full holdings list this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | TRDA | Entrada Therapeutics INC | Stock-Other | 57.09% | +0.05% | — | |
| 2 | DYN | Dyne Therapeutics INC | Stock-Other | 19.40% | +9.12% | — | |
| 3 | HOWL | Werewolf Therapeutics INC | Stock-Other | 19.08% | +13.05% | — | |
| 4 | RPTX | Repare Therapeutics INC | Stock-Other | 4.43% | +2.84% | — |
Reported value over time
Sector allocation
Not enough sector-mapped data yet
Sector allocation over time
Quarterly history
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2025-09-30 | 4 | $44.5M | 100 | |
| 2025-06-30 | 5 | $43.3M | 0 | |
| 2025-03-31 | 6 | $69.4M | 100 | |
| 2024-12-31 | 6 | $124.4M | 0 | |
| 2024-09-30 | 6 | $145.3M | 0 | |
| 2024-06-30 | 6 | $182.1M | 0 | |
| 2024-03-31 | 6 | $245.2M | 0 | |
| 2023-12-31 | 7 | $203.5M | 0 | |
| 2023-09-30 | 7 | $186.7M | 0 | |
| 2023-06-30 | 8 | $203.9M | 0 | |
| 2023-03-31 | 9 | $240.0M | 0 | |
| 2022-12-31 | 9 | $239.0M | 0 | |
| 2022-09-30 | 9 | $262.6M | 0 | |
| 2022-06-30 | 10 | $237.0M | 0 | |
| 2022-03-31 | 10 | $292.6M | 0 | |
| 2021-12-31 | 10 | $462.7M | 0 | |
| 2021-09-30 | 9 | $431.5M | 0 | |
| 2021-06-30 | 9 | $537.9M | 98 | |
| 2021-03-31 | 8 | $517.6M | 31 | |
| 2020-12-31 | 8 | $706.6M | 37 | |
| 2020-09-30 | 8 | $536.3M | 52 | |
| 2020-06-30 | 6 | $336.1M | 69 | |
| 2020-03-31 | 5 | $164.4M | 37 | |
| 2019-12-31 | 5 | $227.2M | 10 | |
| 2019-09-30 | 5 | $233.7M | 11 | |
| 2019-06-30 | 5 | $247.5M | 29 | |
| 2019-03-31 | 7 | $242.5M | 74 | |
| 2018-12-31 | 6 | $118.2M | 23 | |
| 2018-09-30 | 7 | $147.7M | 73 | |
| 2018-06-30 | 9 | $258.2M | 35 | |
| 2018-03-31 | 9 | $259.6M | 25 | |
| 2017-12-31 | 9 | $249.5M | 53 | |
| 2017-09-30 | 8 | $204.9M | 18 | |
| 2017-06-30 | 9 | $230.2M | 14 | |
| 2017-03-31 | 8 | $207.9M | 20 | |
| 2016-12-31 | 8 | $211.9M | 42 | |
| 2016-09-30 | 8 | $305.3M | 10 | |
| 2016-06-30 | 14 | $308.3M | 28 | |
| 2016-03-31 | 15 | $322.7M | 71 | |
| 2015-12-31 | 15 | $560.4M | 20 | |
| 2015-09-30 | 16 | $650.1M | 31 | |
| 2015-06-30 | 15 | $597.6M | 41 | |
| 2015-03-31 | 15 | $468.9M | 11 | |
| 2014-12-31 | 15 | $450.3M | 51 | |
| 2014-09-30 | 13 | $305.6M | 30 | |
| 2014-06-30 | 14 | $297.3M | 78 | |
| 2014-03-31 | 12 | $236.3M | 39 | |
| 2013-12-31 | 12 | $309.6M | 51 | |
| 2013-09-30 | 11 | $354.6M | 55 | |
| 2013-06-30 | 10 | $225.9M | 0 |
Holding changes this quarter
Mpm Asset Management LLC's most significant position changes for 2025-09-30: Sold out: Iteos Therapeutics INC (2662247D); Sold out: Adaptimmune Therapeutics-adr (ADAPY).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | HOWL | Werewolf Therapeutics INC | +13.1% | — | Unchanged |
| 2 | DYN | Dyne Therapeutics INC | +9.1% | — | Unchanged |
| 3 | RPTX | Repare Therapeutics INC | +2.8% | — | Unchanged |
| 4 | TRDA | Entrada Therapeutics INC | +0.1% | — | Unchanged |
| 5 | 2662247D | Iteos Therapeutics INC | — | EXIT | Sold out |
| 6 | ADAPY | Adaptimmune Therapeutics-adr | — | EXIT | Sold out |
FAQ
What is Mpm Asset Management LLC and what type of investor is it?
Mpm Asset Management LLC is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2025-09-30), the firm manages a tracked equity portfolio valued at approximately $44.5M, spread across 4 disclosed positions.
What are Mpm Asset Management LLC's largest equity positions?
Based on the latest 13F filing, Mpm Asset Management LLC's top holdings by market value are:
1. Entrada Therapeutics INC (TRDA) — $25.4M (57.1%)
2. Dyne Therapeutics INC (DYN) — $8.6M (19.4%)
3. Werewolf Therapeutics INC (HOWL) — $8.5M (19.1%)
4. Repare Therapeutics INC (RPTX) — $2.0M (4.4%)
What changes did Mpm Asset Management LLC make in its most recent portfolio filing?
In the latest quarter, Mpm Asset Management LLC took a more defensive posture — trimming 0 positions and completely exiting 2 holdings. The largest of these moves: Sold out: Iteos Therapeutics INC (2662247D); Sold out: Adaptimmune Therapeutics-adr (ADAPY)
What sectors does Mpm Asset Management LLC focus on?
Sector breakdown data is not yet available for Mpm Asset Management LLC. Check back after the next 13F processing cycle.